Advanced spatial and digital technologies may help us to take fuller advantage of limited testing resources to monitor the infection status of a large population in a cost-effective manner. Moreover, they may provide additional evidence to supplement results of nucleic acid testing (NAT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to decrease false-negative and false-positive rates.
Keywords: COVID-19; SARS-CoV-2; nucleic acid testing; spatial epidemiology; spatial lifecourse epidemiology; spatial technology.
Copyright © 2021 Elsevier Ltd. All rights reserved.